Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page
Trump Says Stopping Iran Nukes Matters More Than Americans’ Cost-Of-Living Concerns: ‘I Don’t Think…’

Trump Says Stopping Iran Nukes Matters More Than Americans’ Cost-Of-Living Concerns: ‘I Don’t Think…’

by Snigdha Gairola | May 17, 2026 | General

President Donald Trump defended his comments on the economic impact of the Iran conflict, saying preventing Tehran from obtaining a nuclear weapon is more important than Americans’ rising cost-of-living concerns. Trump Defends Iran War On Friday, speaking to Fox...
BlackRock Eyes Up To $10 Billion Stake In SpaceX IPO As Elon Musk Targets Historic $1.75 Trillion Debut: Report

BlackRock Eyes Up To $10 Billion Stake In SpaceX IPO As Elon Musk Targets Historic $1.75 Trillion Debut: Report

by Mohd Haider | May 17, 2026 | General

BlackRock Inc. (NYSE:BLK) is reportedly in discussions to invest $5 billion to $10 billion in SpaceX‘s upcoming initial public offering, as the world’s largest asset manager looks to anchor the potentially record-breaking offering. Biggest-Ever IPO In Play BlackRock...

Lucid’s Robotaxi Ambitions Advance As Executive Takes First Ride In Uber-Nuro Partnership Vehicle

by Nabaparna Bhattacharya | May 16, 2026 | General

Lucid Group, Inc. (NASDAQ:LCID) executive Nick Twork shared his first experience riding inside the company’s upcoming autonomous robotaxi service. Twork described the trip as smooth and natural in a post published Friday on X. The Lucid communications chief said...

Dr. Reddy’s Launches Generic Semaglutide In Canada, Expands GLP-1 Push

by Nabaparna Bhattacharya | May 16, 2026 | General

Dr. Reddy’s Laboratories Limited (NYSE:RDY) on Friday launched its generic Semaglutide Injection in Canada. This move is significant as it positions Dr. Reddy’s among the first companies to introduce this generic product in the Canadian market, which is a notable...

Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data

by Nabaparna Bhattacharya | May 16, 2026 | General

Candel Therapeutics, Inc. (NASDAQ:CADL) on Friday presented new clinical data at the American Urological Association (AUA) 2026 Annual Meeting. This presentation highlighted the extended follow-up data from a pivotal phase 3 trial of aglatimagene besadenovec in...
« Older Entries
Next Entries »

Recent Posts

  • Michael Dell Reaffirms $250 Trump Accounts Pledge to 25M Children, Says It Gives Them ‘A Real Stake’ in America
  • Bitcoin, Ethereum, XRP, Dogecoin Rally as ‘Extreme Fear’ Persists: Analyst Expects a ‘Quick’ Move Upward for BTC After ‘Shallow’ Correction
  • The Fed’s Next Move? The Surprising ETFs Set To Win if Hikes Return
  • AMD CEO Lisa Su Once Said She Fell in Love With Chips Thanks to an Accidental Part-Time Job: ‘Careers Are Very Much by Chance’
  • Bernie Sanders Slams Trump on 250th Anniversary of US Independence, Says His Administration Is Not ‘America First’

Recent Comments

    Archives

    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.